Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Quest Diagnostics

Do Wall Street Analysts Like Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

Barchart

What You Need To Know Ahead of Quest Diagnostics' Earnings Release

Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in earnings.

Barchart

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings

Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday.

Benzinga

Quest Diagnostics Reports Q3 Earnings, Shares Slide

Shares of Quest Diagnostics (NASDAQ:DGX) are falling Tuesday after the medical laboratories company shared mixed earnings results.

Benzinga

What to Expect From Quest Diagnostics’ Next Quarterly Earnings Report

Quest Diagnostics is gearing up to announce its third-quarter results in the upcoming week, and analysts expect a notable single-digit growth in earnings.

Barchart

Oura Ring users can now access over 50 blood biomarkers for $99

Oura's new $99 blood test connects your habits to your health.

Android Central

Read news from The Economist, FT, and more,
with one subscription

This Quest Diagnostics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.

Benzinga

Despite Slump, Options Traders May be Seeing Something with Quest Diagnostics (DGX)

While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.

Barchart

What to Expect From Quest Diagnostics' Q2 2025 Earnings Report

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit growth in earnings.

Barchart

Is Quest Diagnostics Stock Outperforming the Nasdaq?

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock?

While Quest Diagnostics has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

Revealed: drug tests in California prisons yielded false positives, affecting thousands of people

Records suggest Quest Diagnostics erroneously detected opiates. Lawyers say parole requests were jeopardized in the process

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Here's What to Expect From Quest Diagnostics’ Next Earnings Report

Quest Diagnostics is expected to release its Q1 results this month, and analysts expect a single-digit surge in earnings.

Barchart

Is Quest Diagnostics Stock Outperforming the S&P 500?

Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock’s prospects.

Barchart

How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks?

Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock?

Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know

With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth.

Barchart

Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Quest Diagnostics’ Q2 2024 Earnings: What to Expect

As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Reason

Should You Be Able To Take an Alzheimer's Test at Home?

Plus, an AI-generated version of the same article

Android Central

You can help Google with its latest Fitbit study on metabolic health

Fitbit and Pixel Watch owners can participate in a metabolic health study, which involves providing digital health data and a blood sample.

Fortune

Workers test positive for weed at highest rate since 1997

Amphetamine use is on the rise as well.

St. Louis Post-Dispatch

Legal pot raises questions about the future of workplace drug policies in Missouri

ST. LOUIS — While marijuana legalization proponents celebrated victory in their fight for recreational cannabis, Missouri business owners were phoning their lawyers.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Alzheimer Society

44 stories

DGX

39 stories

the Alzheimer Association

37 stories

Diagnostics

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.